Free Trial

Neumora Therapeutics (NMRA) Insider Trading & Ownership

Neumora Therapeutics logo
$1.97 +0.19 (+10.67%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$1.92 -0.05 (-2.49%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neumora Therapeutics (NASDAQ:NMRA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
26.94%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$10.00M
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$390.05K
Get NMRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neumora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NMRA Insider Buying and Selling by Quarter

Neumora Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/17/2026
Daljit Singh Aurora
Insider
Sell6,165$3.56$21,947.40  
2/17/2026
Joshua Pinto
Joshua Pinto
President
Sell5,967$3.54$21,123.18  
2/17/2026Sell1,436$3.56$5,112.16  
2/17/2026Sell9,819$3.51$34,464.69  
11/11/2025
Daljit Singh Aurora
Insider
Sell114,703$2.68$307,404.04  
10/27/2025
Arch Venture Partners Xii, Llc
Major Shareholder
Buy1,915,700$2.61$4,999,977.00  
10/27/2025Buy1,915,700$2.61$4,999,977.00  
(Data available from 1/1/2013 forward)

NMRA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Neumora Therapeutics includes Amgen Inc, Arch Venture Partners Xii, Llc, Daljit Singh Aurora, Henry O Gosebruch, Joshua Pinto, Kristina Burow, Matthew K Fust, Michael Lee Milligan, Paul L Berns, and Robert A Lenz. Learn more on insiders at NMRA.

26.94% of Neumora Therapeutics stock is owned by insiders. Learn more on NMRA's insider holdings.

The following insiders have purchased NMRA shares in the last 24 months: Arch Venture Partners Xii, Llc ($4,999,977.00), and Kristina Burow ($4,999,977.00).

Insiders have purchased a total of 3,831,400 NMRA shares in the last 24 months for a total of $9,999,954.00 bought.

The following insiders have sold NMRA shares in the last 24 months: Daljit Singh Aurora ($329,351.44), Joshua Pinto ($738,714.58), Matthew K Fust ($239,254.47), Michael Lee Milligan ($8,454.98), Paul L Berns ($34,464.69), and Robert A Lenz ($447,106.91).

Insiders have sold a total of 258,654 Neumora Therapeutics shares in the last 24 months for a total of $1,797,347.07 sold.



This page (NASDAQ:NMRA) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners